ADC Bio Secures Additional Equity Round Investment
Extra funding for strategic move into downstream formulation and fill-finish capabilities and full exploitation of Lock-Release as new ADC manufacturing paradigm...
Extra funding for strategic move into downstream formulation and fill-finish capabilities and full exploitation of Lock-Release as new ADC manufacturing paradigm...
Conjugation Process Improvements – Application of Lock Release Technology – Poster presented at the Protein Engineering Summit (Boston)...
ADC Biotechnology has successfully secured a £1.14m investment from Downing LLP to finance innovative bioconjugation and their US expansion plans...
ADCBIO presented at World ADC Conference on their conjugation process technologies...
ADC BIO announces the development of a revolutionary, ‘downstream bio-conjugation’ method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and manufacturing....
ADC BIO has signed a partnership agreement with multi-disciplined engineering specialists, WHP. ...
Experts at ADC Bio warn of impending problems in the ADC pipeline with millions wasted in development costs....
ADC BIO has secured investment for the construction of an $11 million bioconjugation facility at its new site in Deeside, North Wales, UK. ...